BIOLOGICAL E. LIMITED PARTNERS WITH BAVARIAN NORDIC TO INCREASE GLOBAL ACCESS TO CHIKUNGUNYA VACCINE
The manufacturing agreement is the first step in working together to provide Chikungunya Vaccine to low-and middle-income countries The initial technology transfer will be followed by commercial manufacturing, which has the potential to generate up to 300 new jobs at BE Biological E. Limited (BE) today announced